Flexeril (cyclobenzaprine) generally stays in your system for about 5.5 to 16.5 days after your last dose, depending on how quickly your body processes it. The wide range comes from the drug’s highly variable half-life, which the FDA reports as 18 hours on average but anywhere from 8 to 37 hours across individuals.
How the Detection Window Is Calculated
A drug is considered effectively cleared from your body after roughly 5.5 half-lives. Since cyclobenzaprine’s half-life ranges from 8 to 37 hours, the math works out to a clearance window of about 2 days on the short end and up to 16.5 days on the long end. Most people fall somewhere in between. If you’ve been taking Flexeril for several days or weeks rather than a single dose, the drug accumulates in your body and will take longer to fully clear.
Factors That Slow Elimination
Several things push you toward the longer end of that detection window.
Age is one of the biggest factors. Research on cyclobenzaprine pharmacokinetics found that elderly subjects had plasma concentrations twice as high as younger adults on the same dose. Older bodies simply process the drug more slowly, which means it lingers longer in urine.
Liver health matters just as much. Cyclobenzaprine is broken down in the liver, and even mild liver impairment can double the drug’s concentration in the blood compared to someone with normal liver function. If your liver isn’t working at full capacity for any reason, expect a slower clearance time.
Dose and duration also play a role. A single 5 mg tablet clears faster than weeks of consistent dosing at higher amounts. With repeated use, the drug builds up in your tissues and takes longer to wash out completely. Body size and overall metabolic rate can shift the timeline as well, though these effects are harder to quantify.
Does Flexeril Show Up on a Drug Test?
Standard workplace drug panels (the typical 5-panel or 10-panel tests) do not screen for cyclobenzaprine. It is not a controlled substance and is not grouped with the drugs those panels target, such as opioids, amphetamines, or marijuana. So in most routine testing situations, Flexeril will not be flagged.
However, there is an important catch. Cyclobenzaprine is structurally very similar to tricyclic antidepressants, and it can trigger a false positive for TCAs on immunoassay screening tests. If your drug panel includes a TCA screen, which some expanded panels and hospital screenings do, Flexeril may cause a positive result even though you’re not taking an antidepressant. A follow-up confirmatory test (typically gas chromatography or mass spectrometry) will distinguish cyclobenzaprine from actual tricyclic antidepressants and resolve the false positive.
If you know you’ll be tested and you’re taking Flexeril, having your prescription information available can help clear up any confusion quickly.
Why the Range Is So Wide
A 5.5-to-16.5-day window is unusually broad compared to many medications, and that’s because cyclobenzaprine is eliminated quite slowly relative to other muscle relaxants. An 18-hour average half-life is already on the longer side, but the fact that some people process it in 8 hours while others take 37 hours creates a nearly fivefold difference in clearance time. Your individual result depends on the combination of age, liver function, dose history, and metabolism described above. There is no single number that applies to everyone.
For a rough estimate: if you’re a younger adult with normal liver function who took Flexeril for a few days, expect it to be undetectable within about a week. If you’re older, have any liver issues, or used it consistently for a longer period, two weeks or slightly more is a reasonable expectation.